Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Immunol Lett ; 69(3): 293-300, 1999 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-10528791

RESUMEN

7-thia-8-oxoguanosine (immunosine) is a nucleoside analogue with immunoenhancing activity. In this work, its effects on proliferation of thymocytes in vitro were studied. It was found that immunosine stimulated proliferation of thymocytes both of mice and rats. The stimulatory effect depended on antigen presenting cells (APC), since thymocytes depleted of accessory cells did not proliferate to immunosine. In addition, pretreatment of APC with immunosine for 24 h significantly increased proliferation of thymocytes. Immunosine stimulated interleukin 2 (IL-2) production and the expression of activation markers (CD25 and CD71). The upregulation of CD25 (alpha subunit of IL-2R) was detected both on thymocytes and thymic dendritic cells. Proliferation of thymocytes in the presence of immunosine was predominantly mediated by IL-2 since blocking IL-2Ralpha by specific monoclonal antibodies inhibited cell proliferation by 65-85%.


Asunto(s)
Sustancias de Crecimiento/farmacología , Guanosina/análogos & derivados , Timo/efectos de los fármacos , Animales , Células Presentadoras de Antígenos/inmunología , División Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Guanosina/farmacología , Interleucina-2/biosíntesis , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos CBA , Ratas , Receptores de Interleucina-2/biosíntesis , Timo/citología , Timo/inmunología , Factores de Tiempo
2.
Fundam Clin Pharmacol ; 14(3): 209-17, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-15602797

RESUMEN

Immunosine (7-thia-8-oxoguanosine) is a novel guanosine analogue showing immunostimulatory activity both in vivo and in vitro. This compound acts on different components of the immune system including B cells, natural killer (NK) cells and antigen-presenting cells (APC). However, its influence on functions of T cells is poorly understood. In this work we studied the effect of immunosine on proliferation of total rat splenocytes and purified T cells triggered by different mitogens and the mechanisms involved. The results demonstrate that immunosine significantly stimulates proliferation of T cells. The effect was dose-dependent and also depended on concentrations of specific stimulators. Maximal stimulation was seen using 250 microM immunosine. The stimulatory effect of immunosine on lymphocyte proliferation triggered by Concanavalin A (Con A) correlated with increased interleukin 2 (IL-2) production and upregulation of the IL-2 receptor alpha (IL-2Ralpha) expression. The dependency of T-cell proliferation on IL-2/IL-2R was confirmed using neutralizing anti-IL-2Ralpha monoclonal antibodies (mAbs). Higher concentrations of immunosine in the presence of optimal concentrations of Con A (5 microg/mL) inhibited proliferation of T cells. A similar stimulatory effect of immunosine on proliferation of purified T cells and IL-2 production was observed using an anti-T-cell receptor (TCR) mAb and a combination of anti-TCR mAb and IL-2. However, the guanosine analogue did not significantly modulate proliferation of T cells triggered by IL-2 alone. When the combination of phorbol myristate acetate (PMA) and ionomycin was used for T-cell stimulation different results were obtained. Under lower cell stimulation immunosine significantly potentiated T-cell proliferation, expression of IL-2Ralpha and IL-2 production. In the presence of suboptimal stimulation the compound stimulated T-cell proliferation and IL-2Ralpha expression, whereas under maximal stimulation an enhancing effect on IL-2 production was seen. Since direct stimulatory effect of immunosine on T-cell growth in culture was rather weak it can be postulated that the compound acts as a cofactor for T-lymphocyte proliferation.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Guanosina/análogos & derivados , Guanosina/farmacología , Linfocitos T/efectos de los fármacos , Animales , Anticuerpos Monoclonales/farmacología , Células Cultivadas , Concanavalina A/farmacología , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Femenino , Interleucina-2/inmunología , Interleucina-2/metabolismo , Subunidad alfa del Receptor de Interleucina-2 , Masculino , Mitógenos/farmacología , Ratas , Receptores de Interleucina/biosíntesis , Receptores de Interleucina/inmunología , Bazo/citología , Linfocitos T/citología , Linfocitos T/inmunología , Linfocitos T/metabolismo
3.
Artículo en Inglés | MEDLINE | ID: mdl-12690700

RESUMEN

In our previous experiments, we demonstrated that xylazine, an alpha 2-adrenergic agonist, stimulated proliferation of thymocytes triggered by concanavalin A. In contrast, higher concentrations of xylazine were inhibitory. In this work, we studied the mechanisms involved in immunosuppression of xylazine and found that the compound at concentrations between 100 microM and 500 microM induced apoptosis of rat thymocytes in vitro. In addition, xylazine at concentrations higher than 50 microM also induced apoptosis of a thymocyte hybridoma (BWRT8) and increased apoptosis of the line triggered by T cell receptor (TCR) cross-linking. Apoptosis was confirmed by morphological analysis staining with merocyanine 540 and propidium iodide and in cases of BWRT8 by fragmentation of DNA. The mechanisms of xylazine-induced apoptosis of the BWRT8 hybridoma were further examined. We demonstrated that the process in both nonactivated and activated (TCR cross-linking) BWRT8 cells was not prevented by yohimbine (a selective alpha-adrenergic antagonist) and by antibodies to Fas and Fas-L. In contrast, cell death was completely blocked by a caspase inhibitor, z-Val-Ala-Asp (OMe)-CH2F. Cyclosporine, a calcineurin blocker, partly inhibited the xylazine-induced apoptosis of activated BWRT8 cells.


Asunto(s)
Agonistas de Receptores Adrenérgicos alfa 2 , Agonistas alfa-Adrenérgicos/farmacología , Apoptosis/efectos de los fármacos , Hibridomas/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Timo/citología , Timo/efectos de los fármacos , Xilazina/farmacología , Animales , Hibridomas/citología , Masculino , Ratones , Ratas , Receptores Adrenérgicos alfa 2/fisiología , Linfocitos T/citología , Células Tumorales Cultivadas
4.
Methods Find Exp Clin Pharmacol ; 21(9): 583-90, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10669901

RESUMEN

7-thia-8-oxoguanosine (immunosine) is a nucleoside analog showing efficient antiviral activity in rodent models as a consequence of enhancement of the immune response. However, little is known about the mechanisms of its action. In this work the effect of immunosine on proliferation of mouse and rat splenocytes in culture was studied. It was found that the compound stimulated proliferation of lymphocytes in a dose-dependent manner without any additional stimuli. The effect is predominantly mediated by interleukin-2 (IL-2) as judged by increased IL-2 production, upregulation of IL-2 receptor alpha (IL-2R alpha) expression and by significant inhibition (60-75%) of cell proliferation by anti-IL-2R alpha monoclonal antibodies (mAbs). Immunosine also stimulated proliferation both of T- and B-cells purified by immunomagnetic sorting. The response of B-cells was much higher than that of T-cells. The stimulatory effect of immunosine on both lymphocyte subpopulations was further increased by the addition of enriched splenic antigen-presenting cells or purified dendritic cells. Proliferation of purified T-cells to immunosine was also significantly potentiated by an anti-alpha beta T-cell receptor mAb (R 73). All these data suggest that T-, B- and accessory cells in splenic cultures are the targets of immunosine action.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Linfocitos B/efectos de los fármacos , División Celular/efectos de los fármacos , Guanosina/análogos & derivados , Linfocitos/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Animales , Anticuerpos Monoclonales/genética , Células Presentadoras de Antígenos/fisiología , Antivirales/farmacología , Células Cultivadas , Células Dendríticas/fisiología , Relación Dosis-Respuesta a Droga , Femenino , Guanosina/farmacología , Interleucina-2/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos CBA , Ratas , Ratas Wistar , Receptores de Interleucina-2/antagonistas & inhibidores , Receptores de Interleucina-2/efectos de los fármacos , Receptores de Interleucina-2/genética , Bazo/efectos de los fármacos , Factores de Tiempo , Regulación hacia Arriba/efectos de los fármacos
5.
Coll Antropol ; 26(2): 557-63, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12528281

RESUMEN

The extent of the regression of duodenal gastric metaplasia (DGM) after the eradication of Helicobacter pylori infection is controversial. Therefore, we decided to assess the degree of DGM before, sex weeks and one year after H. pylori eradication. 105 consecutive Helicobacter pylori positive patients with endoscopically proven duodenal ulcer, with DGM and Helicobacter pylori infection were recruited for this study. The diagnosis of Helicobacter pylori infection was based on CLO-test and histology, and DGM was assessed on four bulb biopsies taken before, sex weeks and one year after Helicobacter pylori eradication. Histological assessment of Helicobacter pylori associated gastritis was performed according to the Sydney classification. Follow up study on 98 patients before, six weeks and one year after the eradication of Helicobacter pylori showed that the mean extent of DGM did not change significantly after eradication and did not differ when compared with 14 patients with persisting infection. Our results show that the inflammatory process related to Helicobacter pylori does not play the main role in the development of DGM.


Asunto(s)
Úlcera Duodenal/microbiología , Duodeno/patología , Gastritis/microbiología , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Femenino , Mucosa Gástrica/patología , Humanos , Masculino , Metaplasia , Persona de Mediana Edad
8.
Clin Exp Immunol ; 134(1): 63-9, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12974756

RESUMEN

We have studied the effect of mycophenolate mofetil (MMF), a new drug used in prevention of transplant rejection, on differentiation, maturation and allostimulatory activity of human monocyte-derived dendritic cells (MDDC). MDDC were generated in vitro with granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin (IL)-4 in the presence or absence of MMF. MMF reduced the number of immature MDDC in culture, dose-dependently, by inducing apoptosis and inhibited their stimulatory activity on allogeneic lymphocytes. These changes correlated with down-regulation of co-stimulatory and adhesion molecules such as CD40, CD54, CD80 and CD86. No differences were observed in mannose receptor (MR)-mediated endocytosis, measured by the uptake of fluorescein isothiocyanate (FITC)-dextran. MDDC differentiated in the presence of MMF showed significantly reduced maturation upon stimulation with lipopolysaccharide, as judged by lower expresson of CD83 and co-stimulatory molecules, lower production of tumour necrosis factor (TNF)-alpha, IL-10, IL-12 and IL-18 as well as lower stimulation of alloreactive T cells including naive CD4+ CD45RA+ T cells. In contrast, MDDC matured in the presence of MMF showed a more marked decrease in the FITC-dextran uptake than mature MDDC cultivated without MMF and the phenomenon correlated with down-regulation of the MR expression. These results suggest that MMF impairs differentiation, maturation and function of human MDDC in vitro, which is an additional mechanism of its immunosuppressive effect.


Asunto(s)
Citocinas/inmunología , Células Dendríticas/inmunología , Inmunosupresores/farmacología , Ácido Micofenólico/farmacología , Ciclo Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Células Dendríticas/efectos de los fármacos , Células Dendríticas/metabolismo , Relación Dosis-Respuesta a Droga , Endocitosis/efectos de los fármacos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Humanos , Inmunofenotipificación , Interleucina-4/farmacología , Lectinas Tipo C/metabolismo , Lipopolisacáridos/farmacología , Receptor de Manosa , Lectinas de Unión a Manosa/metabolismo , Ácido Micofenólico/análogos & derivados , Receptores de Superficie Celular/metabolismo , Estimulación Química
9.
Fundam Appl Toxicol ; 4(2 Pt 2): S116-23, 1984 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-6547103

RESUMEN

It has been shown that HI-6 was the most potent oxime so far known in poisoning by sarin, VX , and soman, but its protective effect in tabun poisoning, allegedly due to poor reactivation of inhibited ChE, was much less pronounced. We have found that the thiocholine-like analog of tabun , O-ethyl, N-N- dimethyamino -S-(2-diethylaminoethyl)- thiophosphatemethylsul fomethylate (Ta-S-N+), was very useful in resolving this problem and established the relationship between reactivating and protective effects of PAM-2 Cl, HI-6, and HGG-12 in rats. PAM-2 Cl (protective ratio (PR) = 22.1) and HI-6 (PR = 24.8), combined with atropine, were very effective against Ta-S-N+ poisoning and reactivating inhibited RBC AChE in vitro and rat blood ChE in vivo. The inefficiency of PAM-2 Cl (PR = 1.6) and HI-6 (PR = 2) in tabun poisoning was due to their inadequacy to reactive tabun -inhibited ChEs . The protective effects of HGG-12 in tabun (PR = 2.8) and Ta-S-N+ poisoning (PR = 2.6) were low, and in the absence of any reactivation of inhibited ChEs , have been attributed to its direct pharmacological effects, which were much more potent in the comparison with PAM-2 Cl or HI-6. It is concluded that the reactivation of inhibited ChE is of decisive importance in the efficient protection in poisoning by tabun and other known chemical warfare nerve agents, whereas their direct pharmacological effects are of limited value, allowing survival of animals only against a few LD50s .


Asunto(s)
Colina/análogos & derivados , Reactivadores de la Colinesterasa/farmacología , Intoxicación por Organofosfatos , Compuestos de Pralidoxima/farmacología , Compuestos de Piridinio/farmacología , Tiocolina/análogos & derivados , Animales , Atropina/farmacología , Colinesterasas/sangre , Femenino , Cobayas , Corazón/efectos de los fármacos , Humanos , Dosificación Letal Mediana , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Organofosfatos , Oximas , Nervio Frénico/efectos de los fármacos , Ratas , Tiocolina/envenenamiento
10.
Int J Immunopharmacol ; 22(3): 203-12, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10685003

RESUMEN

7-thia-8-oxoguanosine (immunosine) is a guanosine analogue showing immunostimulatory activity on different components of the immune system, including B lymphocytes, natural killer cells and macrophages. However, little is known about its effect on T-cell functions. In this work it was demonstrated that immunosine at concentrations between 10 microM and 1 mM stimulated proliferation of rat thymocytes in vitro triggered by suboptimal concentrations of concanavalin A (Con A). The effect correlated with increased interleukin 2 (IL-2) production, upregulation of the IL-2 receptor alpha (IL-2Ralpha) expression and decreased apoptosis of thymocytes in comparison to the effect of Con A alone.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Concanavalina A/farmacología , Guanosina/análogos & derivados , Activación de Linfocitos/efectos de los fármacos , Linfocitos T/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Femenino , Guanosina/farmacología , Interleucina-2/biosíntesis , Masculino , Ratas , Receptores de Interleucina-2/análisis , Linfocitos T/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA